Loading...
PRIVATE.ME Docs
Explore ACIs
PRIVATE.ME PLATFORM

xBlind: Clinical Trial Blinding

Distribute treatment assignment blinding across independent custodians. No single authority can reveal assignments prematurely. Unblinding requires threshold quorum with full audit trail.

AI / ML COMING SOON XorIDA Powered
Section 01

The Problem

Clinical trial blinding is a single-authority decision. One corrupt, coerced, or compromised administrator can break the blind for any subject, undermining the scientific validity of the entire trial and potentially endangering patients.

Double-blind trials depend on a single Interactive Response Technology (IRT) system maintaining treatment assignments. The IRT vendor, the sponsor's unblinded statistician, or a determined insider can access the complete randomization table. A single breach exposes all assignments.

The consequences are severe. Premature unblinding can bias clinical outcomes, trigger regulatory rejection of the trial, waste years of research and billions in investment, and in some cases endanger patient safety through biased treatment decisions.

The Old Way

Assignments Drug vs. Placebo All subjects IRT System Single vendor control Full randomization table SINGLE POINT OF UNBLINDING Coercion Insider
Section 02

The PRIVATE.ME Solution

xBlind splits treatment assignments into N shares using XorIDA and distributes them to independent custodians. No single custodian can reveal assignments. Unblinding requires K custodians to collaborate, with every request audit-logged.

At randomization, each subject's treatment assignment is split into N shares. Each share goes to a different independent custodian -- a separate organization with no relationship to the others. Unblinding requires K custodians to submit their shares simultaneously, with HMAC verification ensuring no share was tampered with.

Emergency unblinding is preserved. For patient safety, a designated quorum of custodians can unblind a single subject. The protocol is threshold-based: fast enough for medical emergencies, but requiring consensus that prevents unauthorized access.

The New Way

Assignment Drug / Placebo XorIDA Split K-of-N threshold HMAC per share Custodian A Custodian B Custodian C Unblind Quorum only
Section 03

How It Works

Treatment assignments are split at randomization, distributed to independent custodians, and reconstructed only when a threshold quorum approves unblinding. Every step is audit-logged for regulatory compliance.

Randomize Assign treat. XorIDA Split assign. K-of-N CRO share HMAC tagged IRB share HMAC tagged DSMB share HMAC tagged Quorum K custodians HMAC verify Audit logged Unblind Revealed
Key Security Properties
No single custodian can reveal treatment assignments -- unblinding requires K-of-N quorum. Custodians are organizationally independent (CRO, IRB, DSMB). HMAC integrity verification prevents share tampering. Every unblinding request is immutably audit-logged for regulatory review. Emergency single-subject unblinding preserves patient safety.
Section 04

Use Cases

Pharma
Phase III Clinical Trials

Protect double-blind integrity for pivotal trials with thousands of subjects. Threshold blinding prevents premature unblinding by any single party.

FDA-ready
Regulatory
Compliant Blinding

Provide regulators with cryptographic proof that the blind was maintained throughout the trial. Immutable audit trail satisfies FDA 21 CFR Part 11.

audit-compliant
Multi-Site
Multi-Site Coordination

Coordinate blinding across dozens of clinical sites without a central IRT bottleneck. Each site interacts with independent custodians for their subjects.

distributed
Safety
Emergency Unblinding

Enable rapid single-subject unblinding for medical emergencies. Threshold protocol requires minimal quorum while maintaining audit trail and preserving the blind for all other subjects.

patient-safety
Section 05

Integration

Quick Start
import { blindAssignment, requestUnblind } from '@private.me/trialguard';

// Blind a treatment assignment across 3 custodians (2-of-3)
const shares = await blindAssignment('SUBJ-0042', 'active', {
  n: 3,
  k: 2,
  custodians: ['cro', 'irb', 'dsmb'],
});

// Emergency unblinding — requires quorum approval
const result = await requestUnblind('SUBJ-0042', {
  reason: 'SAE — immediate treatment decision required',
  requestor: 'dr.smith@site-12.org',
});
if (result.ok) {
  // result.value.treatment — 'active' or 'placebo'
  // result.value.auditId — immutable audit log reference
}
blindAssignment(subjectId: string, treatment: string, config: { n: number, k: number }): Promise<BlindShare[]>
Splits a treatment assignment into N shares using XorIDA and distributes them to independent custodians. Each share is HMAC tagged. No single custodian can determine the treatment assignment. Returns share references for audit tracking.
requestUnblind(subjectId: string, request: UnblindRequest): Promise<Result<UnblindResult>>
Initiates a quorum-based unblinding request. K custodians must approve and submit their shares. Verifies HMAC integrity, reconstructs the treatment assignment, and creates an immutable audit log entry. Supports single-subject emergency unblinding.
Section 06

Security Properties

PropertyMechanismGuarantee
ConfidentialityXorIDA threshold sharingInformation-theoretic
IntegrityHMAC-SHA256 per shareTamper-evident
AvailabilityK-of-N reconstructionFault tolerant
AuditabilityImmutable audit logRegulatory compliant
Patient SafetyEmergency unblind protocolSingle-subject quorum
56
Tests
93%
Coverage
7
Modules
0
Runtime Deps
VERIFIED BY XPROVE

Cryptographic Proof of Correctness

This ACI's computations can be cryptographically verified by xProve — so regulators, auditors, and counterparties can confirm results without re-running the computation or accessing the underlying data.

XPROVE INTEGRATION
Tier 1: HMAC audit trail — always on, ~1.3x overhead.
Tier 2: Commit-and-reveal — anti-equivocation for Beaver triples.
Tier 3: IT-MACs — malicious-security detection between parties.
Tier 4: KKW zero-knowledge proofs — publicly verifiable, ~50 KB, post-quantum.

Read the xProve white paper →
GET STARTED

Ready to deploy xBlind?

Talk to Ren, our AI sales engineer, or book a live demo with our team.

Book a Demo

© 2026 StandardClouds Inc. dba PRIVATE.ME. All rights reserved.

VERIFIABLE WITHOUT CODE EXPOSURE

Ship Proofs, Not Source

xBlind generates cryptographic proofs of correct execution without exposing proprietary algorithms. Verify integrity using zero-knowledge proofs — no source code required.

XPROVE CRYPTOGRAPHIC PROOF
Download proofs:

Verify proofs online →

Use Cases

🏛️
REGULATORY
FDA / SEC Submissions
Prove algorithm correctness for distributed systems without exposing trade secrets or IP.
Zero IP Exposure
🏦
FINANCIAL
Audit Without Access
External auditors verify secure operations without accessing source code or production systems.
FINRA / SOX Compliant
🛡️
DEFENSE
Classified Verification
Security clearance holders verify distributed systems correctness without clearance for source code.
CMMC / NIST Ready
🏢
ENTERPRISE
Procurement Due Diligence
Prove security + correctness during RFP evaluation without NDA or code escrow.
No NDA Required